| P2093 | author name string | Guus A M S van Dongen | |
| | Gerard W M Visser | |
| | Rob C Roovers | |
| | Lars R Perk | |
| | Maria J W D Vosjan | |
| | Paul M P van Bergen En Henegouwen | |
| | Marijke Stigter-van Walsum | |
| P2860 | cites work | Indium-111-labeled anti-EGFr-425 scintigraphy in the detection of malignant gliomas | Q48176716 |
| | Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner | Q48272311 |
| | Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients. | Q50595029 |
| | Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neck. | Q53608148 |
| | Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules. | Q54673289 |
| | Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma | Q68184538 |
| | An approach for immunoradiometric assay with metallic radionuclides: gallium-67-deferoxamine-dialdehyde starch-IgG | Q70144264 |
| | Gallium-67/gallium-68-[DFO]-octreotide--a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies | Q72742120 |
| | Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs | Q73128251 |
| | The gallium-deferoxamine complex: stability with different deferoxamine concentrations and incubation conditions | Q77325829 |
| | Computer controlled 68Ga milking and concentration system | Q82709023 |
| | Evaluation of bifunctional chelates for the development of gallium-based radiopharmaceuticals | Q82995132 |
| | Nanobodies - from llamas to therapeutic proteins | Q86490967 |
| | Untangling the ErbB signalling network | Q27860884 |
| | Naturally occurring antibodies devoid of light chains | Q28269589 |
| | Microwave-supported preparation of (68)Ga bioconjugates with high specific radioactivity | Q31062644 |
| | 68Ga-labeling of biotin analogues and their characterization | Q33447625 |
| | 68Ga-labelled recombinant antibody variants for immuno-PET imaging of solid tumours | Q33531425 |
| | p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging | Q33629386 |
| | EGFR signaling and drug discovery. | Q34096763 |
| | A 2-helix small protein labeled with 68Ga for PET imaging of HER2 expression | Q34435496 |
| | Molecular imaging in cancer | Q34530970 |
| | Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies | Q34567940 |
| | The promise of immuno-PET in radioimmunotherapy | Q36011321 |
| | Nanobodies in therapeutic applications. | Q36908555 |
| | 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals | Q37126389 |
| | Radiolabelled proteins for positron emission tomography: Pros and cons of labelling methods | Q37691848 |
| | Immuno-positron emission tomography: shedding light on clinical antibody therapy | Q37779796 |
| | Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocol. | Q39112621 |
| | MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck. | Q39113030 |
| | A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue. | Q39743982 |
| | Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-Z EGFR:2377 Affibody molecule: aspect of the injected tracer amount | Q39786140 |
| | PET of EGFR antibody distribution in head and neck squamous cell carcinoma models | Q39838100 |
| | Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET. | Q39903960 |
| | Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors. | Q39985672 |
| | Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT. | Q39991878 |
| | SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression | Q40009259 |
| | Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody | Q40177482 |
| | (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab. | Q40354841 |
| | Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors. | Q40354849 |
| | Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugates | Q40404320 |
| | A phase I study of 99mTc-hR3 (DiaCIM), a humanized immunoconjugate directed towards the epidermal growth factor receptor | Q40617716 |
| | Relationship between the parameters cellular differentiation, doubling time and platinum accumulation and cisplatin sensitivity in a panel of head and neck cancer cell lines | Q41110917 |
| | AMIDE: a free software tool for multimodality medical image analysis | Q42614465 |
| | Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine | Q43111522 |
| | Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology | Q43865789 |
| | Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess | Q45158523 |
| | NODAPA-OH and NODAPA-(NCS)n: synthesis, 68Ga-radiolabelling and in vitro characterisation of novel versatile bifunctional chelators for molecular imaging | Q46332081 |
| | Gallium-68-DOTA-albumin as a PET blood-pool marker: experimental evaluation in vivo | Q46430107 |
| | Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies | Q46569961 |
| P433 | issue | 4 | |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 753-763 | |
| P577 | publication date | 2011-01-06 | |
| P1433 | published in | European Journal of Nuclear Medicine and Molecular Imaging | Q15708890 |
| P1476 | title | Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET. | |
| P478 | volume | 38 | |